Growth-promoting therapies frequently prescribed to counteract the adult height loss associated with classical congenital adrenal hyperplasia (CAH) may provide greater height benefits in boys, according to a large multicenter study recently published in The Journal of Clinical Endocrinology & Metabolism. The findings reveal a gender-dependent difference in how effectively these commonly deployed hormonal interventions preserve […]
